Tags

Type your tag names separated by a space and hit enter

Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients.
Int J Food Sci Nutr. 2011 Sep; 62(6):609-16.IJ

Abstract

The present study evaluated the anti-hyperglycemic and lipid-lowering properties of Emblica officinalis Gaertn. fruit in normal and diabetic human volunteers. The results indicated a significant decrease (P < 0.05) in fasting and 2-h post-prandial blood glucose levels on the 21st day in both normal and diabetic subjects receiving 1, 2 or 3 g E. officinalis powder per day as compared with their baseline values. Significant (P < 0.05) decreases were also observed in total cholesterol and triglycerides in both normal and diabetic volunteers on day 21 that were given either 2 or 3 g E. officinalis powder per day. However, diabetic volunteers receiving only 3 g E. officinalis powder exhibited a significant (P < 0.05) decrease in total lipids on day 21. Both normal and diabetic volunteers receiving 2 or 3 g E. officinalis powder significantly (P < 0.05) improved high-density lipoprotein-cholesterol and lowered low-density lipoprotein-cholesterol levels.

Authors+Show Affiliations

Department of Pharmacy, University of Sargodha, Sargodha, Pakistan.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

21495900

Citation

Akhtar, Muhammad Shoaib, et al. "Effect of Amla Fruit (Emblica Officinalis Gaertn.) On Blood Glucose and Lipid Profile of Normal Subjects and Type 2 Diabetic Patients." International Journal of Food Sciences and Nutrition, vol. 62, no. 6, 2011, pp. 609-16.
Akhtar MS, Ramzan A, Ali A, et al. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609-16.
Akhtar, M. S., Ramzan, A., Ali, A., & Ahmad, M. (2011). Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. International Journal of Food Sciences and Nutrition, 62(6), 609-16. https://doi.org/10.3109/09637486.2011.560565
Akhtar MS, et al. Effect of Amla Fruit (Emblica Officinalis Gaertn.) On Blood Glucose and Lipid Profile of Normal Subjects and Type 2 Diabetic Patients. Int J Food Sci Nutr. 2011;62(6):609-16. PubMed PMID: 21495900.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. AU - Akhtar,Muhammad Shoaib, AU - Ramzan,Ayesha, AU - Ali,Amanat, AU - Ahmad,Maqsood, Y1 - 2011/04/18/ PY - 2011/4/19/entrez PY - 2011/4/19/pubmed PY - 2012/2/18/medline SP - 609 EP - 16 JF - International journal of food sciences and nutrition JO - Int J Food Sci Nutr VL - 62 IS - 6 N2 - The present study evaluated the anti-hyperglycemic and lipid-lowering properties of Emblica officinalis Gaertn. fruit in normal and diabetic human volunteers. The results indicated a significant decrease (P < 0.05) in fasting and 2-h post-prandial blood glucose levels on the 21st day in both normal and diabetic subjects receiving 1, 2 or 3 g E. officinalis powder per day as compared with their baseline values. Significant (P < 0.05) decreases were also observed in total cholesterol and triglycerides in both normal and diabetic volunteers on day 21 that were given either 2 or 3 g E. officinalis powder per day. However, diabetic volunteers receiving only 3 g E. officinalis powder exhibited a significant (P < 0.05) decrease in total lipids on day 21. Both normal and diabetic volunteers receiving 2 or 3 g E. officinalis powder significantly (P < 0.05) improved high-density lipoprotein-cholesterol and lowered low-density lipoprotein-cholesterol levels. SN - 1465-3478 UR - https://www.unboundmedicine.com/medline/citation/21495900/Effect_of_Amla_fruit__Emblica_officinalis_Gaertn___on_blood_glucose_and_lipid_profile_of_normal_subjects_and_type_2_diabetic_patients_ L2 - https://www.tandfonline.com/doi/full/10.3109/09637486.2011.560565 DB - PRIME DP - Unbound Medicine ER -